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Aim To investigate the value of genomic information in 
prediction of individual serum uric acid concentrations.
Methods Three population samples were investigated: 
from isolated Adriatic island communities of Vis (n = 980) 
and Korčula (n = 944), and from general population of the 
city of Split (n = 507). Serum uric acid concentration was 
correlated with the genetic risk score based on 8 previ-
ously described genes: PDZK1, GCKR, SLC2A9, ABCG2, LR-
RC16A, SLC17A1, SLC16A9, and SLC22A12, represented by 
a total of 16 single-nucleotide polymorphisms (SNP). The 
data were analyzed using classification and regression tree 
(CART) and general linear modeling.
Results The most important variables for uric acid predic-
tion with CART were genetic risk score in men and age in 
women. The percent of variance for any single SNP in pre-
dicting serum uric acid concentration varied from 0.0%-
2.0%. The use of genetic risk score explained 0.1%-2.5% of 
uric acid variance in men and 3.9%-4.9% in women. The 
highest percent of variance was obtained when age, sex, 
and genetic risk score were used as predictors, with a total 
of 30.9% of variance in pooled analysis.
Conclusion Despite overall low percent of explained vari-
ance, uric acid seems to be among the most predictive 
human quantitative traits based on the currently available 
SNP information. The use of genetic risk scores is a valuable 
approach in genetic epidemiology and increases the pre-
dictability of human quantitative traits based on genomic 
information compared with single SNP approach.
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Uric acid is the end product of purine metabolism in hu-
mans and higher primates and was initially believed to be 
a highly potent risk factor for disease development (1). This 
was confirmed in different studies that reported increased 
levels of serum uric acid in metabolic disorders and cancer 
(2-4). However, recent studies have reported possible ben-
eficial effects of uric acid, especially in cardiovascular and 
neurological diseases of late onset (5,6). Possible protective 
effects are due to a strong antioxidant properties of uric 
acid (7). All these findings make uric acid a highly interest-
ing research target in both epidemiology and genetics.
Efforts in the search for the genetic basis of uric acid con-
centrations have been focused on several candidate genes 
(8,9) and the recently described SLC2A9 has been found 
to be a gene with a major effect in humans, especially in 
women (10,11). SLC2A9, also known as Glut 9, is a member 
of the SLC2A facilitative glucose transporter family, which 
has an important role in the sugars metabolism (12). The 
gene encodes a putative transporter of 540 amino ac-
ids, which is closely related to several more members of 
the same gene family, with 44% and 38% resemblance to 
Glut5 and Glut1, respectively (12). The protein consists of 
12 transmembrane domains, sugar motifs, and other sig-
natures which facilitate sugars transport (13). The long 
form of this protein in humans is most strongly expressed 
in basolateral membranes of proximal renal tubular cells, 
the liver, and placenta, while the short isoform shows the 
strongest expression in the apical membranes of polarized 
renal tubular cells and in the placenta (12,14). Furthermore, 
it is expressed in chondrocytes from human articular car-
tilage, functioning as the key link between uric acid in se-
rum and its deposits in gout (15). Three mRNA species have 
been described: a major transcript of 1.9 kb and 2 other 
transcripts of 3.1 and 5.0 kb, found primarily in the kidney 
and liver, but present at low levels in several other tissues 
(12). SLC2A9 was localized to chromosome 4 (4p15.3-p16) 
using a monochromosomal human/rodent somatic cell 
hybrid mapping panel (12). A recently published meta-
analysis based on the 28 141 samples from 14 popula-
tions confirmed the strongest association of uric acid with 
SLC2A9 and also indicated several more genes that had 
smaller contribution in the overall uric acid variance, but 
reached genome-wide significance level (16).
The initial discovery of the SLC2A9 and its association with 
uric acid was made on the samples from the isolated com-
munity of island of Vis (10,17). This is a well-characterized 
research population, with great amount on information 
on its history and demographics (18-21), basic popu-
lation genetics, and other genetic properties (22-24). One 
such study reported increased odds of nephrolithiasis in 
isolated populations (25), which was attributed to the ex-
istence of consanguinity in some of the island populations 
(18,26-30). Subsequent efforts in gene mapping in two of 
the Croatian Adriatic islands (Vis and Korčula) yielded a 
number of interesting results, including findings on genet-
ic influence on height determination (31,32), lung function 
(33), chronic kidney disease (34), and levels of fasting glu-
cose (35), serum lipids (36-38), creatinine (39), and plasma 
N-glycans (40), supporting the initial proposal that isolat-
ed populations present a very valuable and fundamentally 
advantageous research resource (17,18,41).
The aim of this study was to investigate the role of a set 
of 8 previously described genes in predicting the serum 
concentrations of uric acid in samples from 3 populations 
in Croatia.
POPuLaTIOn anD MeThODs
study population
This study was conducted on samples from 3 populations. 
The first sample included 986 unselected participants from 
the isolated community of the Croatian Adriatic island 
of Vis, recruited in 2003 and 2004. The second included 
944 unselected adult participants from the eastern parts 
of the Korčula island, recruited in 2007. The third sample 
comprised 535 unselected adult participants from the city 
of Split, as a mainland control for the isolated communi-
ties. All participants were informed on the study aims and 
signed the informed consent before entering the study. 
Relevant ethics committees in Scotland and Croatia gave 
consent for the study performance.
Measurements
We conducted serum uric acid measurements at each of the 
3 study sites (Vis, Korčula, and Split). After the blood extrac-
tion, blood samples were promptly centrifuged, aliquoted, 
and stored at -70°C. Subsequently, the samples were trans-
ported into the single certified laboratory in Zagreb, where 
all samples were analyzed using the uricase UV photometry 
by Olympus AU400 (Olympus Corp, Tokyo, Japan).
Genotyping
All 3 samples have extensive genetic information. Vis island 
sample was genotyped with Illumina HumanHap 300 chip, 
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with a total of 317 503 SNPs, while Korčula and Split sam-
ples were genotyped with Human CNV370 chip, contain-
ing 346 027 markers (32,42-44).
All 3 data sets were used to extract SNPs from the genes 
that were associated with the serum uric acid concentra-
tions in the previous studies (16). Some of these SNPs were 
not available in all 3 samples. In these cases, we used the 
closest available SNP from the same gene that was pres-
ent in all 3 data sets, resulting in a total of 16 SNPs associ-
ated with uric acid, belonging to a total of 8 genes (Table 
1). Based on this information, genetic score was calculated 
for each individual. The score was defined as the weight-
ed sum of the information from the selected alleles, with 
weights proportional to the percent of variance explained 
in a previously published meta-analysis (16). Each allele 
within the same gene was weighted with the equal per-
cent of variance that was reported for a given gene. Ge-
netic risk scores were calculated using PLINK version 1.00 
(Center for Human Genetic Research, Massachusetts Gen-
eral Hospital and the Broad Institute of Harvard & MIT, Cam-
bridge, MA, USA), using “score” option (45).
statistical analysis
Classification and regression tree (CART), a simple predic-
tive data mining technique, was used in predicting the 
uric acid concentration. The model was built with untrans-
formed uric acid values and a total of 20 predictor vari-
ables: age, sex, study site, genetic risk score, and 16 select-
ed SNPs. Ten crossvalidations were used in order to avoid 
model over-fitting. The main result of this approach is the 
variable importance, a numerical representation of the 
strength of association between the predictors and pre-
dicted variable. Importance is also expressed as the nor-
malized estimate for each predictor, where the strongest 
predictor is assigned a value of 100%, while the others are 
ranked according to their decreasing relative importance. 
Additionally, CART was also used to define the age limit at 
which the strongest change in the uric acid concentration 
is recorded. This model was calculated for women only. Fur-
thermore, general linear modeling was used to estimate 
the percent of variance explained (adjusted R2) by either 
genetic risk scores or the single SNP, and also to estimate 
the maximum percent of variance explained by age, sex, 
and genomic information. Four general linear models were 
based on various predictors, aiming to investigate the per-
cent of variance of serum uric acid that was attributed to 
these predictors. The initial model was built with age and 
sex as predictor variables in order to establish the predic-
tive value of these 2 variables. The second model was built 
for every sub-sample and SNP, and the range of R2 was re-
corded (the smallest and the greatest values are reported 
in the table), in order to establish the possibility to use any 
single SNP in uric acid concentration prediction. The third 
model was built with genetic risk scores only in order to 
allow comparison with the models which included single 
SNP only. The final, fourth model was based on age, sex 
study site, and genetic risk score. In order to obtain the nor-
mal data distribution, serum uric acid was log transformed. 
TaBLe 1. Genes, their corresponding chromosomes, and single-nucleotide polymorphisms (snP) included in this study
Gene abbreviation Gene aliases Corresponding protein name Chromosome snP
PDZK1 CLAMP, NHERF3, 
PDZD1
Na(+)/H(+) exchange regulatory cofactor NHE-RF3  1 rs1797052
rs1298954
GCKR – Glucokinase regulatory protein (also glucokinase hexokinase 4 
regulator)
 2 rs780094
SLC2A9 GLUT9 Solute carrier family 2, facilitated glucose transporter member 9 
(also glucose transporter type 9)
 4 rs13129697
rs4447863
rs13131257
rs6449213
rs1014290
rs733175
ABCG2 ABC15, BMDP, CDw338ATP-binding cassette sub-family G member 2 (also ABC trans-
porter; breast cancer resistance protein)
 4 rs2231142
LRRC16A CARMIL Leucine rich repeat containing 16  6 rs9358856
SLC17A3 NAPI-1, NPT1 Solute carrier family 17 member 3  6 rs9393672
rs942379
SLC16A9 MCT9 Solute carrier family 16 member 9 10 rs2242206
SLC22A12 URAT1 Solute carrier family 22 member 12 11 rs2078267
rs505802
GENETICS OF URIC ACID REGULATION26 Croat Med J. 2010; 51: 23-31
www.cmj.hr
The same predictor set was used in both CART and general 
linear modeling. The analysis was performed in SPSS (SPSS 
Inc, Chicago, IL, USA), with significance set at P < 0.05.
ResuLTs
A total of 2431 samples were included in the analysis, with 
the most samples from Vis Island and the fewest from Split 
(Table 2). The breakdown according to basic characteristics 
indicated a number of significant differences across these 
samples (Table 2).
The use of CART in the initial model indicated that sex was 
the most influential predictor variable for the entire data 
set, without an indication of differences across samples 
(web extra material 1). The subsequent models were made 
for each sex separately, indicating that the most influen-
tial variable in men was genetic risk score, while in wom-
en it was age (web extra material 1). Due to the fact that 
we observed a strong deflection point in women, we used 
another CART model where only age was forced into the 
classification in order to find the age when the strongest 
change is recorded. It was recorded between 51 and 52 
years, which was also confirmed by the scatterplot, where-
as men had more or less similar values of uric acid across 
age groups (web extra material 2). The final CART model 
was made for 2 groups of women: those aged ≤52 years 
and those older than 52 years. In the younger group, the 
most influential variable was genetic risk score, while in the 
older it was age (web extra material 1).
TaBLe 2. Basic characteristics of the 3 samples included in the analysis
Trait Vis island Korčula island split P
sex; no. (%):
men 409 (41.7) 336 (35.6) 219 (43.2)  0.004*
women 571 (58.3) 608 (64.4) 288 (56.8)
age in years; median (interquartile range)  56.0 (24.0) 57.0 (20.0) 51.0 (22.0) <0.001†
uric acid (μmol/L); median (interquartile range) 303.0 (129.0) 288.0 (108.0) 279.0 (120.0) <0.001
Genetic risk score‡; median (interquartile range) 0.955 (0.566) 0.960 (0.236) 1.128 (0.558) <0.001
Total 980 944 507   –
*χ2 test.
† Kruscall-Walis test.
‡Calculated only for participants who were typed at all 16 loci was used for statistical comparison among the three locations.
TaBLe 3. Percent of variance explained (R2) based on the general linear modeling, where serum uric acid was the predicted variable, 
while different predictors were used in each model
site
Model 1
(age and sex)*
Model 2
(genetic risk score)
Model 3
(single single-nucleotide
polymorphisms)
Model 4
(age, sex, study site,
and genetic risk score)*
Vis:
women  7.7 3.9 0.0-2.0 11.2
men  0.2 0.1 0.0-0.1  0.2
total 17.4 1.5 0.0-1.7 18.9
Korčula:
women 10.5 4.9 0.0-1.7 16.9
men  0.2 2.5 0.0-1.1  2.3
total 25.3 2.6 0.0-1.6 30.8
split:
women  3.4 4.5 0.0-1.8  7.9
men  0.3 0.8 0.0-0.6  0.5
total 19.2 2.4 0.0-1.4 21.4
Pooled analysis:
women  8.1 3.9 0.0-1.6 17.5
men  0.1 0.7 0.0-1.0  1.1
total 20.1 1.8 0.0-1.7 30.9
*sex was removed as predictor variable from the sex-stratified models; study site was also used as a predictor variable in the pooled analysis of all 
three samples in order to adjust for the potential differences among the populations.
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General linear models indicated that age and sex were 
strong predictors, with as much as 20.1% of explained 
variance in the pooled model (Table 3). Genetic risk score 
alone explained up to 4.9% of variance in women and 2.5% 
in men, while single SNPs explained up to 2% in women 
and 1.1% in men (Table 3). Finally, the model with 4 predic-
tors explained a total of 30.9% of variance in pooled analy-
sis (Table 3).
DIsCussIOn
This study demonstrated that serum uric acid had relative-
ly high percent of explained variance based on the SNP 
information. Similar studies report very low percent of vari-
ance, usually less than a single percent (46). This suggests 
that SNPs might not be the best approach to utilize ge-
nomic information or that there is greater likelihood of the 
common disease rare variant hypothesis, which implies 
that most of genetic variation is due to rare genetic vari-
ants. Regardless on the mechanism, this study also shows 
an interesting age and sex modifying effects. Classification 
and regression tree results in our study showed that genet-
ic risk score was the most important variable for prediction 
of serum uric acid concentration in men, while general lin-
ear modeling suggested lower overall variance. We also 
found a strong modifying effect of age in women, mean-
ing that for women 52 years old or younger the most im-
portant variable was genetic risk score, while in the older 
group it was age. Such results were reported before for uric 
acid, suggesting strong sex-related and sex-and-age-relat-
ed stratification and likely differential metabolism determi-
nants and uric acid role (10,47-49). Furthermore, previous 
studies often reported rather complex metabolic pathways 
of uric acid with numerous links, including high correlation 
to some other traditional cardiovascular risks (50).
The use of any single SNP in this study suggested that most 
of the association between SNPs and uric acid had very low 
percent of explained variance, despite the significant asso-
ciation of some of these SNPs with uric acid, reported in 
previous studies (10). The application of genetic risk score 
increased these figures, suggesting that it could substan-
tially improve the estimates of variance used in genetic ep-
idemiology (51). The main advantage of genetic risk score 
use is closely related to the predicted genetic architecture 
of complex traits. Currently we believe that complex traits 
are determined by a large number of genetic influences 
of small effect. The association of any single SNP with the 
complex trait is likely to explain just a small amount of vari-
ance, usually not reaching more than a few percents (even 
for the SNPs that show significant associations with the in-
vestigated trait) (10). However, a methodological step for-
ward is the use of large number of SNPs, which are expect-
ed to increase the amount of variance when compared 
with single SNP approach (51). However, the existing ge-
notyping and computational resources might still be in-
sufficient to use genetic risk scores at a sufficient level (52). 
A simulation study suggested that even the use of a rath-
er broad set of 1000 markers in a case-control study with 
10 000 samples provided a relative risk of only 1.04 (52), 
which is currently considered as a very low risk in tradi-
tional epidemiological studies. Therefore, it seems that the 
predictability of uric acid based on the currently available 
genomic information is very low, which is similar to most 
human quantitative traits (51). One of the exciting possi-
bilities could be to calculate the risk scores on all available 
genomic information, thus producing a hypothetical maxi-
mum percent of variance for any given trait. However, the 
main disadvantage of this approach is related to the fact 
that genetic risk score calculation completely ignores pos-
sible interaction between various genes, which are likely 
present and important in human genome (53).
Two analytic approaches were employed in this study – 
classification and regression tree and general linear mod-
eling. The first method is often used for its speed, logical 
simplicity, and general data mining tasks, in cases when 
there is little a priori knowledge or any coherent set of the-
ories or predictions about which variables are related and 
how (54). This is an often-encountered situation in genetic 
epidemiology, and even more in the new approaches of 
systems biology, where a lot of studies are hypothesis-free 
and hypothesis-generating. This is the case even with the 
genome-wide association study, which is actually a data 
mining equivalent since no prior hypothesis is set and a 
number of available genetic markers are associated with 
an outcome variable of interest. Such an approach offers 
a unique opportunity to discover completely new and un-
expected pathways and other modifiers, as it provides a 
measure for association of the investigated trait with every 
available SNP marker. However, each genome-wide asso-
ciation study must be considered as a hypothesis-gener-
ation only, and requires at least 2 following steps – rep-
lication study and further follow-up (bioinformatics or a 
functional genomics study). This study was based on 3 sim-
ilar populations, which allowed both stratified and pooled 
analysis. The similarity of the general pattern of uric acid 
prediction in all 3 samples makes it likely that this is very 
close to the real uric acid pattern, thus supporting the 
results and conclusion presented here.
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The second approach, general linear modeling, provides 
a more traditional measure that should always be report-
ed with genome-wide association results – the percent 
of variance explained by genetic factor(s). Although this 
method offers a range of advantages over the bivariate 
statistics, it also has certain limitations, such as the prob-
lem of shared variance, when 2 or more loci may have the 
same pathway and the introduction of additional loci does 
not bring in further useful information. The indication of 
the shared variance is seen in the cases where the sum of 
variance explained by all individual loci does not add up to 
the total variance explained by the genetic risk scores. This 
study also shows a substantial amount of shared variance, 
which may be attributable to the fact that some genes 
were represented by more than one SNP or it could be due 
to similar metabolic actions of some of these genes. A step 
forward in the clearing out the amount of shared variance 
could be performed in a multi-level approach, where per-
cent of variance is correlated with linkage disequilibrium 
between markers and then compared with their interac-
tion, thus helping to understand the pathways between 
and among various loci in serum uric acid determination.
The genetic determination of uric acid seems to fit well 
into the polygenic trait theory, where a number of genes 
are expected to influence a single trait (55). However, uric 
acid also seems to be under strong single gene effect of SL-
C2A9, which was described to explain up to 5% of variance 
of uric acid in women (10). Due to this, uric acid seems to 
be a good candidate for genetic studies that describe the 
determination of complex human traits. Furthermore, it 
offers the increased chances for the development of vari-
ous diagnostic and treatment opportunities for individuals 
who suffer symptoms of gout (11).
The limitations of this study include possible differences in 
some features of the 3 samples, which could have affected 
the results (in terms of dietary pattern, possible other ex-
posures, and random effects). There is also much smaller 
interquartile range of genetic risk score in Korčula sample 
than in the other 2 samples. The calculation of the genet-
ic risk score could have overestimated the percent of vari-
ance due to possible shared variance by 2 or more alleles. 
Furthermore, the genetic risk scores were based on an un-
even number of SNPs, which could have affected the re-
sults. However, similarity of the general pattern of variance 
explained among all 3 samples suggests that there might 
be similar mechanisms that include the genetic effects 
on serum concentrations of uric acid. Finally, the results 
could have been affected by the varying extent of 
relatedness among participants, since it is likely that indi-
viduals from isolated populations share higher percent of 
genetic and environmental factors than those from the 
outbred, control population. Despite the limitations, this 
study confirms some previous suggestions of strong sex-
related differences in genetic determination of serum uric 
acid concentration. Although the overall level of explained 
variance and also predictive value of genetic factors was 
low, uric acid seems to be among the human quantitative 
traits that show high percent of variance, reaching values 
close to 5% in women.
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